Cargando…
Do radioiodine-avid lymph nodes from differentiated thyroid cancer on the initial posttherapy scan need repeated (131)I therapy?
BACKGROUND: Residual/recurrent lymph node metastase (LNM) is often found after differentiated thyroid cancer (DTC) surgery. This study aimed to investigate whether patients complicated with radioiodine-avid ((131)I+) lymph nodes from DTC on the initial posttherapy scan (PTS) need repeated (131)I the...
Autores principales: | Jiang, Yongji, Liu, Simin, Qiu, Xiaotong, Huo, Yanlei, Zhang, Xiaoying, Cai, Haidong, Lv, Zhongwei, Ma, Chao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10262046/ https://www.ncbi.nlm.nih.gov/pubmed/37324259 http://dx.doi.org/10.3389/fendo.2023.1099449 |
Ejemplares similares
-
Redifferentiation of Radioiodine Refractory Differentiated Thyroid Cancer for Reapplication of I-131 Therapy
por: Hong, Chae Moon, et al.
Publicado: (2017) -
Positive BRAFV600E mutation of primary tumor influences radioiodine avidity but not prognosis of papillary thyroid cancer with lung metastases
por: Huang, Shuhui, et al.
Publicado: (2022) -
Cervical lymph node metastasis prediction of postoperative papillary thyroid carcinoma before (131)I therapy based on clinical and ultrasound characteristics
por: Yu, Fei, et al.
Publicado: (2023) -
Nontoxic Goiter (NTG) and Radioiodine: What Do Patients Think About It? Quality of Life in Patients with NTG Before and After 131-I Therapy
por: Kaniuka-Jakubowska, Sonia, et al.
Publicado: (2018) -
Embryonal Rhabdomyosarcoma with Posttherapy Cytodifferentiation and Aggressive Clinical Course
por: Jeyaraju, Maniraj, et al.
Publicado: (2021)